[go: up one dir, main page]

FR2851471B1 - Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison - Google Patents

Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison

Info

Publication number
FR2851471B1
FR2851471B1 FR0302242A FR0302242A FR2851471B1 FR 2851471 B1 FR2851471 B1 FR 2851471B1 FR 0302242 A FR0302242 A FR 0302242A FR 0302242 A FR0302242 A FR 0302242A FR 2851471 B1 FR2851471 B1 FR 2851471B1
Authority
FR
France
Prior art keywords
compounds
active substance
binding
binding agent
vector connected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0302242A
Other languages
English (en)
Other versions
FR2851471A1 (fr
Inventor
Anthony R Rees
Patrick Mouchet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synt EM SA
Original Assignee
Synt EM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synt EM SA filed Critical Synt EM SA
Priority to FR0302242A priority Critical patent/FR2851471B1/fr
Priority to PCT/FR2004/000413 priority patent/WO2004075922A2/fr
Publication of FR2851471A1 publication Critical patent/FR2851471A1/fr
Application granted granted Critical
Publication of FR2851471B1 publication Critical patent/FR2851471B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0302242A 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison Expired - Fee Related FR2851471B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0302242A FR2851471B1 (fr) 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison
PCT/FR2004/000413 WO2004075922A2 (fr) 2003-02-24 2004-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisation et lesdits agents de liaison

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0302242A FR2851471B1 (fr) 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison

Publications (2)

Publication Number Publication Date
FR2851471A1 FR2851471A1 (fr) 2004-08-27
FR2851471B1 true FR2851471B1 (fr) 2006-07-28

Family

ID=32799540

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0302242A Expired - Fee Related FR2851471B1 (fr) 2003-02-24 2003-02-24 Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison

Country Status (2)

Country Link
FR (1) FR2851471B1 (fr)
WO (1) WO2004075922A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603512A2 (fr) 2003-03-17 2005-12-14 Albany Molecular Research, Inc. Nouvelles cyclosporines
JP2008514702A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
US7378391B2 (en) 2004-09-29 2008-05-27 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
JP2008515886A (ja) 2004-10-06 2008-05-15 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキンおよびそれらの医用薬剤としての有用性
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3167679D1 (en) * 1980-03-31 1985-01-24 Inst Int Pathologie Cellulaire Pharmaceutical forms, their preparation and compositions containing the same
WO1987005330A1 (fr) * 1986-03-07 1987-09-11 Michel Louis Eugene Bergh Procede pour ameliorer la stabilite des glycoproteines
US5164372A (en) * 1989-04-28 1992-11-17 Fujisawa Pharmaceutical Company, Ltd. Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
JP2001206897A (ja) * 2000-01-26 2001-07-31 Nippon Seibutsu Seizai:Kk ハイドロキシプロリン誘導体
EE200200522A (et) * 2000-03-15 2004-04-15 Bristol-Myers Squibb Pharma Company Toimeainega konjugeerunud ensüüm-lõhustuv peptiid, seda sisaldav farmatseutiline kompositsioon ningühendi kasutamine kasvajavastase ravimina
EP1334128A2 (fr) * 2000-11-02 2003-08-13 Maxygen Aps Nouveaux polypeptides $g(b) interferon multimeres
FR2836474B1 (fr) * 2002-02-22 2004-12-24 Synt Em Composes, compositions et methode pour le transport des molecules de cyclosporine a travers la barriere hemato-encephalique

Also Published As

Publication number Publication date
WO2004075922A3 (fr) 2005-01-20
WO2004075922A2 (fr) 2004-09-10
FR2851471A1 (fr) 2004-08-27

Similar Documents

Publication Publication Date Title
CY2019016I1 (el) Pd-1, υποδοχεας για β7-4, και χρησεις γι΄ αυτον τον σκοπο
NO20052285D0 (no) Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse
BR0014997B1 (pt) concentrado anticongelante, e, composição refrigerante aquosa.
DE60134937D1 (de) Zweifüssiger, laufender Roboter
IT1314226B1 (it) Sacchetto piatto, sigillato.
DK1077976T3 (da) Vandopløselige azoler som bredspektrede antisvampemidler
DK1330458T3 (da) N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
ITTO20000331A0 (it) Composizioni pesticide.
FR2851471B1 (fr) Composes comprenant au moins une substance active et au moins un vecteur relies par un agent de liaison, leurs utilisations et lesdits agents de liaison
IL166730A0 (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-Ä1,3,4-oxadiazol-2-ylÜphenyl)pyridine-3-sulphonamide as an anticancer agent
MXPA03001783A (es) N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida.
BR0008639B1 (pt) dispositivo amortecedor de torção.
ITTO20000371A0 (it) Composizioni pesticide.
DE60213084D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
FR2811911B1 (fr) Dispersions comprenant au moins un agent emulsifiant choisi parmi les polysaccharides, le polysaccharide etant un heteroxylane
ATE252086T1 (de) 4-oxo-1,4-dihydro-3-cinnolinecarbonsäure-amide als antivirusmittel
RU2000116332A (ru) Антгельминтное средство
邹宇泽 et al. Increased Three Times, or Increased Two Times
Pettis Avian Flu
丁一 SGML & HTML
郭健 et al. 秦岭造山带金矿成矿预测 Ξ
杨婕 HELLO! SUMMER
Carmen The Carriage
ES1050686Y (es) Bolsa perfeccionada.
Perović ALGEBRA I

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20071030